U.S., Sept. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07831889) titled 'Hypofractionated Radiotherapy After Breast Reconstruction for Breast Cancer' on Sept. 15.
Brief Summary: This study aims to evaluate the efficacy and safety of hyperfractionated radiotherapy (40Gy/15 fractions) compared to conventional fractionated radiotherapy (50Gy/25 fractions) in breast cancer patients undergoing breast reconstruction through a three-phase randomized controlled non-inferiority clinical trial. The primary objective is to verify that hyperfractionated radiotherapy is non-inferior to conventional fractionated radiotherapy in terms of local area control; the secondary objectives are to compare the main complication...